Get all your news in one place.
100's of premium titles.
One app.
Start reading
Euronews
Euronews
Gabriela Galvin

BIZARRE: Eu regulator backs new alzheimer s treatment reversing initial decision to reject it - You Need To See This

The European Union’s medicines regulator is reversing course on its decision to block a new Alzheimer’s disease treatment, saying the drug can be offered to certain patients under strict safety protocols.

In late March, the European Medicines Agency’s (EMA) drug evaluators said the risks did not outweigh the benefits for the medicine donanemab, which can slow the progression of early-stage Alzheimer’s but also raises the risk of potentially deadly brain swelling and bleeding.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.